Diaceutics PLC
DXRX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -26.6% | 61% | -10.6% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 83% | 88.4% | 69.9% | 79.9% |
| EBITDA | -£0 | £0 | -£0 | £0 |
| % Margin | -9.2% | 20.3% | -7.8% | 17% |
| Net Income | -£0 | £0 | -£0 | -£0 |
| % Margin | -16.5% | 4.4% | -21% | -1.9% |
| EPS Diluted | -0.028 | 0.01 | -0.031 | -0.003 |
| % Growth | -373.1% | 134% | -887.1% | – |
| Operating Cash Flow | £0 | -£0 | £0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | £0 | -£0 | £0 | £0 |